Table 3.

Median survival and 95% confidence interval (CI) by demographics, clinical data, and laboratory tests.

	Median survival time∗	95% CI	p value†
Age (years)
20–39	22	12–32	0.001
≥60	10	7–13
Sex
Female	8	6–10	0.002
Male	17	13–21
Diabetes
Yes	11	6–16	0.017
No	16	11–21
Renal failure
Yes	17	6–28	0.563
No	14	11–17
Pulmonary disease
Yes	12	9–15	0.925
No	22	14–30
Heart disease
Yes	13	10–16	0.793
No	17	11–23
Ferritin
Normal	13	1–39	0.925
Increased	15	12–18
D-dimer
Normal	—	—	—
Increased	14	11–17
AST
Normal	30	16–44	<0.001
Increased	11	9–13
ALT
Normal	13	10–16	0.218
Increased	19	10–28
ALP
Decreased	14	11–17	—
Normal	—	—
Total protein
Decreased	11	8–14	<0.001
Normal	19	13–25
Bilirubin total
Normal	18	14–22	0.075
Increased	12	10–14
Bilirubin nonconjugated
Normal	36	20–52	<0.001
Increased	12	10–14
Creatinine
Normal	31	24–38	<0.001
Increased	10	8–12
BUN
Normal	36	26–46	<0.001
Increased	11	9–13
CRP
Normal	14	10–18	0.484
Increased	13	10–16
RBCs
Decreased	13	10–16	0.091
Normal	30	2–58
Hb
Decreased	12	9–15	—
Normal	30	—
Neutrophils
Normal	36	24–48	<0.001
Increased	11	9–13
Eosinophils
Decreased	10	8–12	<0.001
Normal	30	22–38
Basophils
Decreased	12	10–14	0.015
Increased	17	7–27
Monocytes
Decreased	10	7–13	<0.001
Normal	17	10–24
Lymphocytes
Decreased	12	9–15	<0.001
Normal	36	1–75

†Associated p value with the log rank test. Symbol “—” indicates value that cannot be calculated due to low number of events (death). ∗Survival time calculated in days. BUN: blood urea nitrogen; CRP: C-reactive protein; Hb: hemoglobin; AST: aspartate aminotransferase; ALT: alanine aminotransferase; ALP: alkaline phosphatase.